Search Within

Kenneth K Ng

  1. "Body Imaging Service"
Formats
  1. Journal Article (6)
  2. Meeting Abstract (6)
Groups
  1. Body Imaging Service (12)
  2. Department of Medicine (12)
  3. Radiology, Department of (12)
  4. Solid Tumor Oncology Division (12)
  5. Thoracic Oncology (12)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (11)

More Groups

People
  1. Charles Rudin (11)
  2. Juliana Eng (7)
  3. Afsheen Iqbal (6)
  4. Mark Kris (6)
  5. Paul Paik (5)
  6. Andreas Rimner (4)

More People

Years
  1. 2024 (1)
  2. 2023 (1)
  3. 2022 (2)
  4. 2021 (1)
  5. 2020 (1)
  6. 2018 (3)

More Years

Publications
  1. Clinical Cancer Research (3)
  2. International Journal of Radiation Oncology, Biology, Physics (2)
  3. Journal of Clinical Oncology (2)
  4. Journal of Thoracic Oncology (2)
  5. Cancer Discovery (1)
  6. Lung Cancer (1)

More Publications

Publishers
  1. American Association for Cancer Research (4)
  2. Elsevier Inc. (4)
  3. American Society of Clinical Oncology (2)
  4. Elsevier Ireland Ltd. (1)
  5. Nature Publishing Group (1)

Results (12)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase I/II study of valemetostat (DS-3201b), an EZH1/2 inhibitor, in combination with irinotecan in patients with recurrent small-cell lung cancer
    Journal Article

    Choudhury, N. J.; Lai, W. V.; Makhnin, A.; Heller, G.; Eng, J.; Li, B.; Preeshagul, I.; Santini, F. C.; Offin, M.; Ng, K.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Phase I dose escalation trial combining olaparib and thoracic radiation therapy in extensive-stage small cell lung cancer
    Meeting Abstract

    Rimner, A.; Lok, B.; Gelblum, D. Y.; Kotecha, R. R.; Albrecht, F.; Shin, J. Y.; Laplant, Q.; Namakydoust, A.; Shepherd, A.; Gomez, D.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Final analysis of consolidative use of radiotherapy to block (CURB) oligoprogression trial - A randomized study of stereotactic body radiotherapy for oligoprogressive metastatic lung and breast cancers
    Meeting Abstract

    Tsai, C. J.; Yang, J. T.; Guttmann, D. M.; Shaverdian, N.; Eng, J.; Yeh, R.; Girshman, J.; Das, J.; Gelblum, D.; Xu, A. J.; more...
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save
  • Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer
    Journal Article

    Jee, J.; Lebow, E. S.; Yeh, R.; Das, J. P.; Namakydoust, A.; Paik, P. K.; Chaft, J. E.; Jayakumaran, G.; Brannon, A. R.; Benayed, R.; more...
    Nature Medicine (2022)

    Fulltext@MSK | Save
  • Consolidative use of radiotherapy to block (CURB) oligoprogression: Interim analysis of the first randomized study of stereotactic body radiotherapy in patients with oligoprogressive metastatic cancers of the lung and breast
    Meeting Abstract

    Tsai, C. J.; Yang, J. T.; Guttmann, D. M.; Shaverdian, N.; Shepherd, A. F.; Eng, J.; Gelblum, D.; Xu, A. J.; Namakydoust, A.; Iqbal, A.; more...
    International Journal of Radiation Oncology, Biology, Physics (2021)

    Fulltext@MSK | Save
  • A phase II trial of albumin-bound paclitaxel and gemcitabine in patients with newly diagnosed stage IV squamous cell lung cancers
    Journal Article

    Paik, P. K.; Kim, R. K.; Ahn, L.; Plodkowski, A. J.; Ni, A.; Donoghue, M. T. A.; Jonsson, P.; Villalona-Calero, M.; Ng, K.; McFarland, D.; more...
    Clinical Cancer Research (2020)

    Fulltext@MSK | Save
  • A phase II trial of albumin-bound paclitaxel and gemcitabine in patients with newly diagnosed PD-L1 IHC low/unknown stage IV squamous cell lung cancers
    Meeting Abstract

    Paik, P. K.; Srikakulum, A.; Ahn, L. S. H.; Plodkowski, A. J.; Ng, K. K.; McFarland, D.; Fiore, J. J.; Iqbal, A.; Eng, J.; Rudin, C. M.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • A phase II trial of albumin-bound paclitaxel and gemcitabine in patients with newly diagnosed stage IV squamous cell lung cancers
    Meeting Abstract

    Paik, P.; Kim, R.; Ahn, L.; Plodkowski, A.; Ng, K.; McFarland, D.; Iqbal, A.; Eng, J.; Rudin, C.
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save
  • Response to ERBB3-directed targeted therapy in NRG1-rearranged cancers
    Journal Article

    Drilon, A.; Somwar, R.; Mangatt, B. P.; Edgren, H.; Desmeules, P.; Ruusulehto, A.; Smith, R. S.; Delasos, L.; Vojnic, M.; Plodkowski, A. J.; more...
    Cancer Discovery (2018)

    Fulltext@MSK | Save
  • A phase I trial of the Hedgehog inhibitor, sonidegib (LDE225), in combination with etoposide and cisplatin for the initial treatment of extensive stage small cell lung cancer
    Journal Article

    Pietanza, M. C.; Litvak, A. M.; Varghese, A. M.; Krug, L. M.; Fleisher, M.; Teitcher, J. B.; Holodny, A. I.; Sima, C. S.; Woo, K. M.; Ng, K. K.; more...
    Lung Cancer (2016)

    Fulltext@MSK | Save